Statistics
Total Visits
| Views | |
|---|---|
| Randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of Lacticaseibacillus rhamnosus CRL1505 in the prevention of upper respiratory tract infections in a healthy pediatric population | 447 |
Total Visits Per Month
| November 2025 | December 2025 | January 2026 | February 2026 | March 2026 | April 2026 | May 2026 | |
|---|---|---|---|---|---|---|---|
| Randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of Lacticaseibacillus rhamnosus CRL1505 in the prevention of upper respiratory tract infections in a healthy pediatric population | 24 | 22 | 31 | 32 | 28 | 41 | 20 |
File Visits
| Views | |
|---|---|
| Registro IRESP.PROB 2.pdf | 178 |
Top country views
| Views | |
|---|---|
| United States | 109 |
| Germany | 60 |
| Singapore | 58 |
| Hong Kong | 44 |
| Brazil | 35 |
| Ireland | 22 |
| United Kingdom | 15 |
| Vietnam | 15 |
| Spain | 10 |
| South Korea | 8 |
Top cities views
| Views | |
|---|---|
| Frankfurt am Main | 56 |
| Hong Kong | 43 |
| Ashburn | 41 |
| Dublin | 22 |
| San Jose | 14 |
| Singapore | 12 |
| Seoul | 8 |
| Council Bluffs | 6 |
| Buffalo | 5 |
| Hanoi | 5 |
